Come up with a name for your new list and we'll add to it:
Emiliem raised a round of funding on , . Investors include
Michigan Pre-Seed Capital Fund.
Emiliem, Inc., a biopharmaceutical company, is engaged in early oncology R&D. The Company is developing Molecular Targeted Therapeutics (MTTs) for oncology and other indications. MTTs are therapeutic …